Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe and...
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic value of short-term longitudinal clinical and laboratory trajectories for gram-negative bacteremia in intensive care units patients.

Journal of investigative medicine : the official publication of the American Federation for Clinical Research·2026
Same author

From awareness to action: A nationwide survey of infectious diseases and clinical microbiology physicians' perspectives on artificial intelligence in clinical practice.

Digital health·2025
Same author

Aging with HIV: multimorbidity and polypharmacy burden.

AIDS care·2025
Same author

Switching to Long-Acting Cabotegravir and Rilpivirine in Turkey: Perspectives from People Living with HIV in a Setting of Increasing HIV Incidence.

Medicina (Kaunas, Lithuania)·2025
Same author

Epidemiological and clinical analysis, and outcomes of tuberculosis co-infection among people living with HIV in Türkiye (2014-2024) ClinSurv HIV cohort: A large case series.

PloS one·2025
Same author

Ceftazidime-Avibactam Versus Polymyxin-Based Combination Therapies: A Study on 30-Day Mortality in Carbapenem-Resistant Enterobacterales Bloodstream Infections in an OXA-48-Endemic Region.

Antibiotics (Basel, Switzerland)·2024

Related Experiment Videos

SOFA-2 Versus SOFA-1 for Mortality Prediction in Infection-Triggered ICU Patients.

Hakkı Meriç Türkkan1, Umut Özgür1,2, Olcay Dilken3,4,5

  • 1Department of Infectious Diseases and Clinical Microbiology, Şişli Hamidiye Etfal Training and Research Hospital, Istanbul, Türkiye.

Journal of Intensive Care Medicine
|June 19, 2026
PubMed
Summary
This summary is machine-generated.

The updated Sequential Organ Failure Assessment score (SOFA-2) did not outperform the traditional SOFA-1 in predicting 28-day mortality in intensive care unit patients with infections. Both scores showed similar accuracy and clinical utility for risk stratification.

Keywords:
SOFA-2Sequential organ failure assessmentbloodstream infectionintensive care unit mortalitymortality prediction

Related Experiment Videos

Area of Science:

  • Critical Care Medicine
  • Epidemiology
  • Biostatistics

Background:

  • Accurate organ dysfunction assessment is crucial for risk stratification in critically ill patients.
  • The traditional Sequential Organ Failure Assessment score (SOFA-1) reflects outdated clinical practices.
  • The updated SOFA-2 score's prognostic performance in infection-focused intensive care unit (ICU) populations is uncertain.

Purpose of the Study:

  • To compare the prognostic performance of SOFA-1 and SOFA-2 for predicting 28-day mortality.
  • To evaluate SOFA-1 and SOFA-2 in ICU patients with infections, specifically those undergoing blood cultures ≥48 hours after admission.

Main Methods:

  • Retrospective cohort study of 403 adult ICU patients admitted between June 2022 and August 2024.
  • SOFA-1 and SOFA-2 scores calculated at index blood culture time (≥48h post-admission).
  • Mortality prediction assessed via ROC analysis, logistic regression, Cox models, and decision curve analysis.

Main Results:

  • SOFA-2 scores were lower than SOFA-1 in 70% of patients, leading to downward severity reclassification.
  • Discriminative performance for 28-day mortality was similar between SOFA-1 (AUC 0.707) and SOFA-2 (AUC 0.700).
  • Calibration and clinical utility were comparable; only the highest severity category (>10) was independently associated with mortality for both scores.

Conclusions:

  • SOFA-2 did not demonstrate consistent prognostic superiority over SOFA-1 in this infection-triggered ICU cohort.
  • Overall discrimination and clinical utility were similar, with SOFA-2's advantage potentially limited to the highest-risk subgroup.
  • Further validation of SOFA-2 in infection-enriched ICU populations is warranted.